Contact

Get In Touch With Us

Inhibikase Therapeutics is a pharmaceutical company headquartered in Delaware with additional offices in Boston.

A clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of pulmonary arterial hypertension (PAH).

For more information regarding our company, partnerships, or drug candidates, please reach out to us using the information provided.

Delaware Office

1000 N. West Street
Suite 1200
Wilmington, DE 19801

Massachusetts Office

1 Cranberry Hill
Suite 200
Lexington, MA 02421

This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

*Required fields